Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David S Saperstein

Showing results (11-20 of 29) with videos related to

Pageof 3
Sort By:
Current Treatment Options in Neurology|April 5, 2002
Peripheral Neuropathy Due to Cobalamin DeficiencyDavid S. Saperstein, Richard J. Barohn
Neurologic Clinics|May 7, 2013
Laboratory evaluation of peripheral neuropathyTodd D Levine, David S Saperstein
Current Neurology and Neuroscience Reports|January 1, 2003
Current concepts and controversy in chronic inflammatory demyelinating polyneuropathyDavid S Saperstein, Richard J Barohn
The International Journal of Neuroscience|September 6, 2012
Usefulness of skin biopsies in the evaluation and management of patients with suspected small fiber neuropathyDavid S Saperstein, Todd D Levine, Madison Levine, et al.
Neurology International|January 24, 2025
Internal Tremor in Long COVID May Be a Symptom of Dysautonomia and Small Fiber NeuropathySvetlana Blitshteyn, Ilene S Ruhoy, Lauren R Natbony, et al.
Neurologic Clinics|October 29, 2025
Pattern Recognition Approach to Neuropathy and NeuronopathyRichard J Barohn, Gil I Wolfe, David S Saperstein, et al.
Journal of Clinical Neuromuscular Disease|September 3, 2010
Isolated neck extensor myopathy: is it responsive to immunotherapy?Srikanth Muppidi, David S Saperstein, Aziz Shaibani, et al.
Neurologic Clinics|October 29, 2025
Laboratory Evaluation of Peripheral NeuropathyDavid S Saperstein, Todd D Levine, Richard J Barohn, et al.
Muscle & Nerve|October 26, 2019
Cryptogenic small-fiber neuropathies: Serum autoantibody binding to trisulfated heparan disaccharide and fibroblast growth factor receptor-3Todd D Levine, Jafar Kafaie, Lawrence A Zeidman, et al.
Neurology Research International|July 26, 2012
A Pilot Trial of Pioglitazone HCl and Tretinoin in ALS: Cerebrospinal Fluid Biomarkers to Monitor Drug Efficacy and Predict Rate of Disease ProgressionTodd D Levine, Robert Bowser, Nicole C Hank, et al.
Pageof 3

Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
Current Treatment Options in Neurology|April 5, 2002
Peripheral Neuropathy Due to Cobalamin DeficiencyDavid S. Saperstein, Richard J. Barohn
Neurologic Clinics|May 7, 2013
Laboratory evaluation of peripheral neuropathyTodd D Levine, David S Saperstein
Current Neurology and Neuroscience Reports|January 1, 2003
Current concepts and controversy in chronic inflammatory demyelinating polyneuropathyDavid S Saperstein, Richard J Barohn
The International Journal of Neuroscience|September 6, 2012
Usefulness of skin biopsies in the evaluation and management of patients with suspected small fiber neuropathyDavid S Saperstein, Todd D Levine, Madison Levine, et al.
Neurology International|January 24, 2025
Internal Tremor in Long COVID May Be a Symptom of Dysautonomia and Small Fiber NeuropathySvetlana Blitshteyn, Ilene S Ruhoy, Lauren R Natbony, et al.
Neurologic Clinics|October 29, 2025
Pattern Recognition Approach to Neuropathy and NeuronopathyRichard J Barohn, Gil I Wolfe, David S Saperstein, et al.
Journal of Clinical Neuromuscular Disease|September 3, 2010
Isolated neck extensor myopathy: is it responsive to immunotherapy?Srikanth Muppidi, David S Saperstein, Aziz Shaibani, et al.
Neurologic Clinics|October 29, 2025
Laboratory Evaluation of Peripheral NeuropathyDavid S Saperstein, Todd D Levine, Richard J Barohn, et al.
Muscle & Nerve|October 26, 2019
Cryptogenic small-fiber neuropathies: Serum autoantibody binding to trisulfated heparan disaccharide and fibroblast growth factor receptor-3Todd D Levine, Jafar Kafaie, Lawrence A Zeidman, et al.
Neurology Research International|July 26, 2012
A Pilot Trial of Pioglitazone HCl and Tretinoin in ALS: Cerebrospinal Fluid Biomarkers to Monitor Drug Efficacy and Predict Rate of Disease ProgressionTodd D Levine, Robert Bowser, Nicole C Hank, et al.
Pageof 3